Robert Lustig: Liver Fat Changes Are Key to Health, Well-Being, Pancreas Function, and Diabetes Risk
Robert Lustig presents experimental data showing that when de novo lipogenesis dropped by half, liver fat fell 22% while weight stayed the same. This liver fat reduction predicted improved pancreatic insulin response, suggesting a path to reversing insulin resistance.
Questions this video answers
C13-labeled acetate.
It decreased from 50% to 25% (halved).
No change (0).
Decreased by 7%.
Decreased by 22%.
Chapters
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet